Intercure Ltd. (INCR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Intercure Ltd. (INCR:NASDAQ), powered by AI.

Current Price
$0.87
Sector
Healthcare
What is the Intercure Ltd. stock price forecast?

Intercure Ltd. is currently trading at $0.87. View real-time AI analysis on Alpha Lenz.

What is Intercure Ltd. insider trading activity?

View the latest insider trading data for Intercure Ltd. on Alpha Lenz.

What is Intercure Ltd.'s P/E ratio?

View Intercure Ltd.'s valuation metrics on Alpha Lenz.

Intercure Ltd.

NASDAQ · INCR
$0.87+0.00(+0.34%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Intercure Ltd.'s future dividend policy...
Alpha Chat Insight

Intercure Ltd.'s ROE is -9.0%. Explore profitability and growth together.

Ask for details

Company Overview

Intercure Ltd. is a leading pharmaceutical company focused on the development, production, and distribution of cannabis-based products. It stands at the forefront of the medical cannabis industry, leveraging advanced cultivation techniques and proprietary R&D to provide high-quality treatments for a range of medical conditions. Intercure's extensive portfolio includes both therapeutic and wellness products designed to meet the needs of patients and healthcare providers. The company is engaged in several strategic partnerships and collaborations with global leaders in the pharmaceutical and wellness sectors, enhancing its market reach and innovation capabilities. Intercure's operations and distribution networks span multiple countries, positioning it as a key player in the rapidly evolving cannabis market. Through its commitment to rigorous scientific research and regulatory compliance, Intercure is instrumental in advancing the acceptance and integration of medical cannabis into mainstream healthcare solutions. Its active participation in clinical studies and contribution to cannabinoid pharmacology underscores its significant role in the field, supporting informed decisions and elevating health outcomes.

CEOMr. Alexander Rabinovich
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees320

Company Statistics

FY 2025

Profile

N/AMarket Cap
$270.20MRevenue
0.00Shares Out
320Employees

Margins

12.28%Gross
7.90%EBITDA
2.49%Operating
-16.32%Pre-Tax
-13.61%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-11.41%Rev 3Yr
32.96%Rev 5Yr
-45.33%Op Inc 3Yr
14.93%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-5.06%ROA
-9.00%ROE
-3.36%ROIC

Financial Health

$46.47MCash & Cash Equivalents
$247.73MNet Debt
74.22%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Intercure Ltd. (ticker: INCR) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 320 employees.

The current price is $0.874 with a P/E ratio of -x and P/B of -x.

ROE is -9.00% and operating margin is 2.49%. Annual revenue is $270M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Intercure Ltd. (INCR) Stock Forecast 2026 $0.87 — Price, Financials & Analyst Targets | Alpha Lenz